Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Georgian Med News ; (326): 36-39, 2022 May.
Article in English | MEDLINE | ID: mdl-35959874

ABSTRACT

In the world, stroke suffers 5.6-6 million people a year. Stroke deaths are predicted to rise to 6.7 million in 2015 and to 7.8 million in 2030. Stroke is the leading cause of disability worldwide. The provision of specific therapy to patients with stroke in the form of thrombolytic therapy and neurosurgical operations are recognized international standards in the provision of medical care. The advent of computed tomography (CT) in the early 1980s made it possible to further study TLT. In 2014 Joanna M WardlawVeronic, MurrayEivind, Berge Gregory, J del Zoppo searched the Cochrane Stroke Trial Registry (Last November 2013), MEDLINE (1966 to November 2013) and at EMBASE (from 1980 to November 2013). We concluded that thrombolytic therapy administered within six hours of a stroke reduces the proportion of deaths or disability. The dependence of the efficacy and safety of fibrinolytic therapy on the time of its initiation has been demonstrated in a number of large studies. A pooled analysis of the results of the NINDS, ECASS I and II, ATLANTIS studies (n = 2775) showed that the odds ratio (OR) of a favorable outcome of the disease when thrombolysis was initiated in the first 90 minutes of a stroke. Thus, time is the most important condition for the effectiveness of TLT. In addition to the time factor, it is important to take into account the age of patients during TLT. F. Mateen et al. analyzed data from the Canadian TLT registry for patients aged 80 to 89 years and 90 to 99 years. Thus, thrombolysis in patients of various age groups, including those aged 80 to 89 years and older, is equally safe and effective.


Subject(s)
Fibrinolytic Agents , Stroke , Thrombolytic Therapy , Aged, 80 and over , Canada , Cerebrovascular Circulation , Clinical Trials as Topic , Fibrinolytic Agents/adverse effects , Humans , Kazakhstan , Stroke/drug therapy , Thrombolytic Therapy/adverse effects , Treatment Outcome
2.
Zh Nevrol Psikhiatr Im S S Korsakova ; 115(2 Pt 2): 5-7, 2015.
Article in Russian | MEDLINE | ID: mdl-26081330

ABSTRACT

Results of an analysis of inpatients with multiple sclerosis in neurological units of Karaganda hospitals from 2006 to 2013 are presented. The following characteristics were identified: higher percentage of women of the age of 24-34, the prevalence of primary progressive and secondary progressive forms of multiple sclerosis that are most prognostically unfavorable, the level of disability of 52%. Attention is drawn to the fact that only 14% of the patients participate in therapeutic programs.

SELECTION OF CITATIONS
SEARCH DETAIL
...